海翔药业：2025年前三季度净利润约729万元

Company Performance - Haisheng Pharmaceutical reported a revenue of approximately 1.367 billion yuan for the first three quarters of 2025, representing a year-on-year decrease of 5.39% [1] - The net profit attributable to shareholders of the listed company was approximately 7.29 million yuan, reflecting a year-on-year decline of 39.15% [1] - As of the report date, Haisheng Pharmaceutical's market capitalization stood at 9.2 billion yuan [1] Market Context - The A-share market has surpassed 4,000 points, marking a significant resurgence after a decade of stagnation [1] - The technology sector is leading the market's transformation, indicating the emergence of a "slow bull" market pattern [1]